2
Views
0
CrossRef citations to date
0
Altmetric
Review

Poly(ADP-ribose) polymerase inhibition and its potential use in malignant melanoma

Pages 599-605 | Published online: 10 Jan 2014
 

Abstract

Chemotherapy for metastatic malignant melanoma has disappointing response rates, with the majority of patients having resistant disease. One cause of such resistance is the repair of chemotherapy-induced potentially cytotoxic lesions by the DNA repair pathways. Inhibition of the DNA repair enzyme poly(ADP-ribose) polymerase-1 potentiates the cytotoxicity of temozolomide, and this combination has entered early clinical trials and may improve response rates and survival in metastatic melanoma. This review will discuss the rationale for this strategy for chemopotentiation and the early published results of the trials.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.